American Alpha Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$638K Buy
1,812
+72
+4% +$25.7K 0.34% 50
2025
Q4
$570K Buy
1,740
+271
+18% +$86K 0.34% 53
2025
Q3
$415K Sell
1,469
-30
-2% -$8.7K 0.29% 61
2025
Q2
$419K Buy
1,499
+140
+10% +$39.7K 0.33% 62
2025
Q1
$423K Buy
+1,359
New +$401K 0.36% 54

Other funds holding AMGN

American Alpha Advisors's AMGN Position: Q1 2026 in Review

American Alpha Advisors increased its Amgen (AMGN) stake by 4.1% in Q1 2026, buying an estimated $25.7K and bringing the position to 1,812 shares worth $638K. The position accounts for 0.34% of the portfolio, ranked #50.

American Alpha Advisors first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • American Alpha Advisors held 1,812 shares of Amgen worth $638K as of Q1 2026.
  • American Alpha Advisors bought 72 Amgen shares in Q1 2026, an estimated $25.7K.
  • Amgen made up 0.34% of American Alpha Advisors's portfolio in Q1 2026, its #50 holding.
  • American Alpha Advisors first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on American Alpha Advisors's 13F filing for Q1 2026, filed 15 May 2026.